Calgon

Calgon Carbon Corporation is a global leader in the manufacture and supply of activated carbon and purification technologies, with a significant presence in the life sciences and healthcare sectors. The company provides high-purity carbon solutions used for the purification of active pharmaceutical ingredients (APIs), the removal of impurities in nutritional supplements, and the filtration of blood in medical devices such as dialysis and hemoperfusion systems. Its products are essential for meeting pharmacopeia standards in drug manufacturing and for ensuring the safety and efficacy of various medical treatments. Following its acquisition by Kuraray in 2018, Calgon Carbon continues to innovate in filtration media, supporting the pharmaceutical industry's needs for decolorization and contaminant removal.